Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 256,193Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 70UNITED THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9278901

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-05-24

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9278901

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-05-24

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9393203

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-1877

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-27

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 7544713

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-07-14

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9393203

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-1877

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-04-27

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9278901

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-05-24

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 9278901

Drug Substance Claim :

Drug Product Claim :

Application Number : 203496

Patent Use Code : U-1475

Delist Requested :

Patent Use Description : USE OF ORENITRAM FOR T...

Patent Expiration Date : 2024-05-24

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TREPROSTINIL DIOLAMINE

US Patent Number : 8747897

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203496

Patent Use Code : U-2725

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-11

blank